Cpap155 发表于 2025-3-25 03:25:21
http://reply.papertrans.cn/79/7815/781490/781490_21.png放牧 发表于 2025-3-25 10:01:37
E.B. Manoukianncing auditory hallucinations. She also showed impairments of visual perception, language, and praxis (complex motor functions), but no abnormalities of gait or coordination. The patient’s symptoms progressed rapidly, and she died 4½ years after the onset of her illness. At autopsy, Alzheimer reportCROW 发表于 2025-3-25 15:04:02
E.B. Manoukianncing auditory hallucinations. She also showed impairments of visual perception, language, and praxis (complex motor functions), but no abnormalities of gait or coordination. The patient’s symptoms progressed rapidly, and she died 4½ years after the onset of her illness. At autopsy, Alzheimer reportomnibus 发表于 2025-3-25 19:14:06
http://reply.papertrans.cn/79/7815/781490/781490_24.png斜谷 发表于 2025-3-25 21:08:00
E.B. Manoukianncing auditory hallucinations. She also showed impairments of visual perception, language, and praxis (complex motor functions), but no abnormalities of gait or coordination. The patient’s symptoms progressed rapidly, and she died 4½ years after the onset of her illness. At autopsy, Alzheimer report蛙鸣声 发表于 2025-3-26 03:01:22
E.B. Manoukiancancer cells to paclitaxel can result in (1) design of better therapeutic modalities (drug combinations, sequences, schedule of treatment) for the treatment of cancer patients; (2) development of appropriate experimental models that represent as closely as possible the clinical cause of paclitaxel i–FER 发表于 2025-3-26 04:19:09
http://reply.papertrans.cn/79/7815/781490/781490_27.pngDeadpan 发表于 2025-3-26 10:57:39
E.B. Manoukianotype are almost always natural products and their semisynthetic derivatives, and they include agents such as VP-16 (etoposide), doxorubicin, mitoxantrone, and vincristine. Since many of these drugs are therapeutically very useful, elucidation of the mechanisms responsible for causing resistance toIncorporate 发表于 2025-3-26 16:01:53
E.B. Manoukiancancer cells to paclitaxel can result in (1) design of better therapeutic modalities (drug combinations, sequences, schedule of treatment) for the treatment of cancer patients; (2) development of appropriate experimental models that represent as closely as possible the clinical cause of paclitaxel i表脸 发表于 2025-3-26 20:36:51
http://reply.papertrans.cn/79/7815/781490/781490_30.png